A theme involving the loss of control following Medlive's listing on the Hong Kong Stock Exchange, due in part to the lapse of the right to nominate directors, and the resulting transition from a consolidated subsidiary to an equity-method affiliate. Includes recognition of a gain on the loss of control and a gain from the change in ownership interest arising from the issuance of new shares.